XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 37.49

Change

-1.10 (-2.85)%

Market Cap

CAD 0.58B

Volume

5.34K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-21 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-3.08 (-2.38%)

CAD 21.09B
ZSP:CA BMO S&P 500

-1.92 (-2.40%)

CAD 17.10B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-1.25 (-2.28%)

CAD 11.46B
VUN:CA Vanguard US Total Market

-2.42 (-2.48%)

CAD 10.87B
XUS:CA iShares Core S&P 500 Index ETF

-1.07 (-2.36%)

CAD 8.70B
HXS:CA Global X S&P 500 Corporate Cla..

-1.87 (-2.49%)

CAD 4.34B
VSP:CA Vanguard S&P 500 CAD hedged

-1.91 (-2.24%)

CAD 4.04B
QUU:CA Mackenzie US Large Cap Equity ..

-5.52 (-2.62%)

CAD 3.60B
XUU:CA iShares Core S&P US Total Mark..

-1.27 (-2.37%)

CAD 3.34B
ZUE:CA BMO S&P 500 (CAD Hedged)

-1.57 (-2.16%)

CAD 3.23B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -16.52% 9% A- 16% F
Dividend Return 0.20% 17% F 6% D-
Total Return -16.33% 9% A- 16% F
Trailing 12 Months  
Capital Gain 3.25% 56% F 48% F
Dividend Return 1.05% 26% F 17% F
Total Return 4.30% 56% F 42% F
Trailing 5 Years  
Capital Gain 76.01% 71% C- 72% C
Dividend Return 7.45% 24% F 10% F
Total Return 83.46% 59% D- 64% D
Average Annual (5 Year Horizon)  
Capital Gain 14.50% 76% C+ 80% B-
Dividend Return 15.42% 75% C 78% C+
Total Return 0.92% 34% F 36% F
Risk Return Profile  
Volatility (Standard Deviation) 15.12% 37% F 54% F
Risk Adjusted Return 101.99% 61% D- 93% A
Market Capitalization 0.58B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.